Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ACTRN12626000509369) titled 'Ultra-hypofractionated external beam radiation therapy with risk-adapted brachytherapy boost in localised prostate cancer' on April 23.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: South Eastern Sydney Local Health District
Condition:
Prostate Cancer
Prostate Cancer
Cancer - Prostate
Intervention:
Risk-Adapted Brachytherapy + External Beam Radiation: An escalated dose of 18Gy is given to the tumour within the prostate and a reduced dose of 12Gy is giv...